Approximately 11 people will end their lives by suicide today in Canada, according to the Canadian Association for Suicide Prevention. Because awareness is essential to changing this behaviour and understanding why people consider suicide and attempt to take their own lives, Suicide Prevention Week is taking place February 1-7.
McGill Group for Suicide Studies (MGSS) is a multidisciplinary team of researchers using complementary approaches to understand what makes people at risk for suicide.
McGill/ The Douglas Mental Health University Institute experts:
Prof. Gustavo Turecki, Director, McGill Group for Suicide Studies, Medical Chief, Depressive Disorders Program, Douglas Institute
Vice-Chair, Research and Academic Affairs, Department of Psychiatry, McGill University
Co-Director, Douglas – Bell Canada Brain Bank (suicide studies)
Director, Réseau québécois sur le suicide, les troubles de l’humeur et les troubles associés – RQSHA
Professor, McGill University, Departments of Psychiatry, Human Genetics, and Neurology & Neurosurgery
Past-President, International Academy of Suicide Research
Expertise: Suicide, depressive disorders, treatment-resistant major depressive disorder, neurobiology, psychiatric genetics, epigenetics
Contact: to book media interviews, via Florence Meney at florence.meney [at] douglas.mcgill.ca
Available for interviews in French and English
McGill Group for Suicide Studies (MGSS): http://mgss.ca/about-us
Canadian Association for Suicide Prevention : http://suicideprevention.ca/